Sponda - Decisions of extraordinary general meeting

Decisions by Sponda Plc's Extraordinary General Meeting

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE  
OR IN PART, IN OR INTO CANADA, JAPAN, OR THE UNITED STATES. 
Sponda Plc        Stock Exchange Release   25 May 2009, 9:55 a.m.

Decisions by Sponda Plc's Extraordinary General Meeting    
Sponda Plc's Extraordinary General Meeting has today, 25 May 2009, approved the
proposal of the Board of Directors of Sponda to authorise the Board of
Directors to decide on a rights offering. 

Pursuant to the authorisation, Sponda's shareholders will have a pre-emptive
right to subscribe for new shares in proportion to their current shareholding
in Sponda. The number of new shares to be issued based on the authorisation may
not exceed 300,000,000 shares. The Board of Directors was authorised to decide
upon other terms of the rights offering. The authorisation also includes a
right to decide on the secondary offering of the remaining shares, if any, as
determined by the Board of Directors. 

The authorisation is in force until 30 June 2009, and it will not replace the
authorisation of 25 March 2009 granted by the Annual General Meeting to the
Board of Directors to decide on a share offering. 


Helsinki, 25 May 2009 
Sponda Plc                                                                      
Board of Directors                                                              

Further information: Kari Inkinen, President and CEO, tel. +358 20 431 3311     


This document is an advertisement for the purposes of applicable measures
imple-menting Directive 2003/71/EC (such Directive, together with any
applicable implementing measures in the relevant home Member State under such
Directive (the "Prospectus Directive"). A prospectus prepared pursuant to the
Prospectus Directive will be published in connection with any offering of
securities, and will be available at subscription locations in Finland. 

The information contained herein is not for release, publication or
distribu-tion, directly or indirectly, in or into Canada, Japan, or the United
States. The information contained herein does not constitute an offer of
securities for sale in the United States, nor may the securities be offered or
sold in the United States absent registration or an exemption from registration
as provided in the U.S. Securities Act of 1933, as amended, and the rules and
regulations thereunder. There is no intention to register any portion of the
offering in the United States or to conduct a public offering of any securities
in the United States. 

The information contained herein shall not constitute an offer to sell or the
solicitation of an offer to buy, nor shall there be any sale of the securities
referred to herein in any jurisdiction in which such offer, solicitation or
sale would be unlawful prior to registration, exemption from registration or
qualifi-cation under the securities laws of any such jurisdiction. 

This communication does not constitute an offer of securities to the public in
the United Kingdom. No prospectus has been or will be approved in the United
Kingdom in respect of the securities. Consequently, this communication is
di-rected only at (i) persons who are outside the United Kingdom, (ii) persons
who have professional experience in matters relating to investments falling
within Article 19(1) of the Financial Services and Markets Act 2000 (Financial
Promo-tion) Order 2005 (the “FP Order”) and (iii) high net worth entities
falling within Article 49(2) of the FP Order, and other persons to whom it may
lawfully be communicated, (all such persons together being referred to as
“relevant per-sons”). Any investment activity to which this communication
relates will only be available to, and will only be engaged with, relevant
persons.  Any person who is not a relevant person should not act or rely on
this document or any of its contents. 

Any offer of securities to the public that may be deemed to be made pursuant to
this communication in any EEA Member State that has implemented the Prospectus
Directive is only addressed to qualified investors in that Member State within
the meaning of the Prospectus Directive. Copies of this announcement are not
being made and may not be distributed or sent into Canada, Japan, or the United
States. 

The Securities may not be offered, sold, taken up, exercised, resold,
renounced, transferred or delivered, directly or indirectly within Australia
except pursu-ant to an exemption from and in compliance with any applicable
securities law. 

Danske Bank A/S, Helsinki Branch and UBS Limited are acting for Sponda Plc and
no one else in connection with the rights offering and will not regard any
other person (whether or not a recipient of this release) as a client in
relation to the rights offering and will not be responsible to anyone other
than Sponda Plc for providing the protections afforded to their respective
clients or for pro-viding advice in relation to the rights offering or any
matters referred to in this release. 

Neither Danske Bank A/S, Helsinki Branch nor UBS Limited accepts any
responsi-bility whatsoever for the contents of this release, and makes no
representation or warranty, express or implied, for the contents of this
release, including its accuracy, completeness or verification, or for any other
statement made or pur-ported to be made by it, or on its behalf, in connection
with Sponda or the or-dinary shares or the rights offering, and nothing in this
release is or shall be relied upon as, a promise or representation in this
respect whether as to the past or future. Danske Bank A/S, Helsinki Branch and
UBS Limited accordingly disclaim to the fullest extent permitted by law all and
any liability whether arising in tort, contract or otherwise (save as referred
to above) which they might otherwise have in respect of this release or any
such statement.